menu
    • menu

    Company profile for Ology Bioservices

    NEW Drugs in Dev: 4
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ology Bio specializes in R&D (both cGMP and non-cGMP), Process Development, and Manufacturing of vaccines and biologics through commercial stage, with full regulatory support. Our ADM facility accommodates development of bulk drug substance with containment up to BSL-3, which is ideal for vaccine and virus manufacturing. Ology Bio has a proprietary vaccine delivery technology and a variety of platform expression systems avail...
    Ology Bio specializes in R&D (both cGMP and non-cGMP), Process Development, and Manufacturing of vaccines and biologics through commercial stage, with full regulatory support. Our ADM facility accommodates development of bulk drug substance with containment up to BSL-3, which is ideal for vaccine and virus manufacturing. Ology Bio has a proprietary vaccine delivery technology and a variety of platform expression systems available to our clients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ology BioservicesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    13200 NW Nano Court. Alachua, FL 32615
    Telephone
    Telephone
    +1 (386) 462-9663
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ologybio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ology-bioservices/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/OlogyBio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Resilience Subsidiary Ology Bioservices Awarded Contract Worth Up To $250M
    Resilience Subsidiary Ology Bioservices Awarded Contract Worth Up To $250M

    09 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220209005461/en

    BUSINESSWIRE
    09 Feb 2022
    Share Share
    Ology Bioservices Enters Phase 1 Clinical Trial for Anti-COVID-19 Monoclonal
    Ology Bioservices Enters Phase 1 Clinical Trial for Anti-COVID-19 Monoclonal

    17 Dec 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201217006024/en/Ology-Bioservices-Enters-Phase-1-Clinical-Trial-for-Anti-COVID-19-Monoclonal-Antibodies

    BUSINESSWIRE
    17 Dec 2020
    Share Share
    Ology Bioservices Enters Phase 1 Clinical Trial for Anti-COVID-19 Antibodies
    Ology Bioservices Enters Phase 1 Clinical Trial for Anti-COVID-19 Antibodies

    17 Dec 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201217006024/en

    BUSINESSWIRE
    17 Dec 2020
    Share Share
    Ology Bioservices Enters Phase 1 Clinical Trial for Anti-COVID-19 Monoclonal
    Ology Bioservices Enters Phase 1 Clinical Trial for Anti-COVID-19 Monoclonal

    17 Dec 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201217006024/en/Ology-Bioservices-Enters-Phase-1-Clinical-Trial-for-Anti-COVID-19-Monoclonal-Antibodies

    BUSINESSWIRE
    17 Dec 2020
    Share Share
    Ology Bioservices Awarded $37 Million by Department of Defense
    Ology Bioservices Awarded $37 Million by Department of Defense

    23 Nov 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201123005408/en

    BUSINESSWIRE
    23 Nov 2020
    Share Share
    Ology Bioservices Awarded US Army Contract to Manage Production of COVID-19
    Ology Bioservices Awarded US Army Contract to Manage Production of COVID-19

    26 Aug 2020

    // PHARMATECH

    https://www.pharmtech.com/view/ology-bioservices-awarded-us-army-contract-to-manage-production-of-covid-19-vaccines-and

    PHARMATECH
    26 Aug 2020
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search